MAZZELLA, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 666
EU - Europa 155
AS - Asia 73
SA - Sud America 8
OC - Oceania 6
AF - Africa 5
Totale 913
Nazione #
US - Stati Uniti d'America 655
IT - Italia 34
DE - Germania 29
FR - Francia 29
IE - Irlanda 20
PK - Pakistan 14
GB - Regno Unito 13
CA - Canada 10
IN - India 10
JP - Giappone 8
CN - Cina 7
AU - Australia 6
BG - Bulgaria 6
IQ - Iraq 6
IR - Iran 5
TR - Turchia 5
CO - Colombia 4
FI - Finlandia 4
SE - Svezia 4
UA - Ucraina 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
HK - Hong Kong 3
NL - Olanda 3
RO - Romania 3
VN - Vietnam 3
CL - Cile 2
NP - Nepal 2
SA - Arabia Saudita 2
TW - Taiwan 2
AT - Austria 1
BR - Brasile 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
KR - Corea 1
MX - Messico 1
PE - Perù 1
PL - Polonia 1
RU - Federazione Russa 1
SG - Singapore 1
Totale 913
Città #
Ashburn 145
Fairfield 49
Houston 39
Buffalo 37
Santa Cruz 36
Seattle 31
Woodbridge 21
Cambridge 20
Dublin 20
Bologna 18
Chicago 17
Boardman 14
Wilmington 13
Lahore 8
Ann Arbor 7
Ottawa 7
Phoenix 7
Clearwater 6
Las Vegas 6
Sofia 6
Southend 6
Melbourne 5
Mountain View 5
Baghdad 4
Bremen 4
Helsinki 4
Istanbul 4
Los Angeles 4
New York 4
Stockholm 4
Taku 4
Bronx 3
Central 3
Dong Ket 3
Fremont 3
Henderson 3
Herndon 3
London 3
Milpitas 3
Mumbai 3
Paris 3
Provo 3
San Diego 3
San Francisco 3
Santiago de Cali 3
Shanghai 3
Tehran 3
Tokyo 3
Venice 3
Alkmaar 2
Chengdu 2
Dallas 2
Dulles 2
Frankfurt Am Main 2
Islamabad 2
Kathmandu 2
Leawood 2
Multan 2
Munich 2
Newcastle Upon Tyne 2
Norwalk 2
Nürnberg 2
Palm 2
Pune 2
Redmond 2
Riva 2
Riyadh 2
Rochester 2
Rome 2
West Lafayette 2
Yellow Springs 2
Amsterdam 1
Andover 1
Auburn 1
Ballwin 1
Basrah 1
Berlin 1
Bethlehem 1
Brisbane 1
Brooklyn 1
Bucaramanga 1
Budapest 1
Budrio 1
Burewala 1
Cairo 1
Clacton-on-Sea 1
Copenhagen 1
Council Bluffs 1
Denver 1
Edison 1
Esslingen am Neckar 1
Fleming Island 1
Hartford 1
Indianapolis 1
Khairpur 1
Kiev 1
Kirkland 1
Kisohigashi 1
Kumar 1
Lake Forest 1
Totale 682
Nome #
Antiinflammatory Effect of Phytosterols in Experimental Murine Colitis Model: Prevention, Induction, Remission Study, file e1dcb331-eaf2-7715-e053-1705fe0a6cc9 225
Curcuma longa Extract Exerts a Myorelaxant Effect on the Ileum and Colon in a Mouse Experimental Colitis Model, Independent of the Anti-Inflammatory Effect, file e1dcb331-7e47-7715-e053-1705fe0a6cc9 112
High Doses of Ursodeoxycholic Acid Up-Regulate the Expression of Placental Breast Cancer Resistance Protein in Patients Affected by Intrahepatic Cholestasis of Pregnancy, file e1dcb32c-469b-7715-e053-1705fe0a6cc9 111
Curcuma longa L. as a therapeutic agent in intestinal motility disorders. 2: Safety profile in mouse., file e1dcb331-7e46-7715-e053-1705fe0a6cc9 109
Interleukin 28 polymorphisms and hepatocellular carcinoma development after direct acting antiviral therapy for chronihepatitis c, file e1dcb333-f326-7715-e053-1705fe0a6cc9 105
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort, file e1dcb32f-7fa5-7715-e053-1705fe0a6cc9 54
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial, file e1dcb337-db42-7715-e053-1705fe0a6cc9 48
Fatty liver in pregnancy: a narrative review of two distinct conditions, file e1dcb334-28e8-7715-e053-1705fe0a6cc9 37
Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Therapy with Direct-Acting Antivirals. A Systematic Review and Meta-Analysis, file e1dcb338-03a8-7715-e053-1705fe0a6cc9 23
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices, file e1dcb333-f0cc-7715-e053-1705fe0a6cc9 17
Prognostic value of the albumin-bilirubin grade for the prediction of post-hepatectomy liver failure: A systematic review and meta-analysis, file e1dcb338-6975-7715-e053-1705fe0a6cc9 13
Complete Remission of Advanced Hepatocellular Carcinoma Treated with Sorafenib and Concomitant Appearance of IgG4- related Diseases. A Case Report, file e1dcb336-b08a-7715-e053-1705fe0a6cc9 11
Utility of Doppler-Ultrasound and Liver Elastography in the Evaluation of Patients with Suspected Pregnancy-Related Liver Disease, file f81eda1f-6a36-436b-8c6c-a8909457c59b 11
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals, file e1dcb332-82ab-7715-e053-1705fe0a6cc9 8
Extracorporeal shock wave lithotripsy for difficult common bile duct stones: a comparison between 2 different lithotripters in a large cohort of patients., file e1dcb32c-5672-7715-e053-1705fe0a6cc9 7
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens, file e1dcb32f-dada-7715-e053-1705fe0a6cc9 7
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients, file e1dcb330-1c0b-7715-e053-1705fe0a6cc9 7
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis, file e1dcb330-4052-7715-e053-1705fe0a6cc9 7
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study, file e1dcb330-2929-7715-e053-1705fe0a6cc9 6
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice, file e1dcb32f-c5b6-7715-e053-1705fe0a6cc9 4
Severe immune thrombocytopenia after peg-interferonalpha2a, ribavirin and telaprevir treatment completion: A case report and systematic review of literature, file e1dcb32e-c716-7715-e053-1705fe0a6cc9 3
null, file e1dcb32f-92aa-7715-e053-1705fe0a6cc9 3
AISF position paper on liver disease and pregnancy, file e1dcb330-13ca-7715-e053-1705fe0a6cc9 3
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis., file e1dcb330-f80f-7715-e053-1705fe0a6cc9 3
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients, file e1dcb332-1b02-7715-e053-1705fe0a6cc9 3
Prognostic value of the albumin-bilirubin grade for the prediction of post-hepatectomy liver failure: A systematic review and meta-analysis, file 92c0684c-3553-441c-96a4-7c48305e0b42 2
Generation of a novel antibody probe to the Apical Sodium-Dependent Bile Acid Transporter that inhibits ileal bile acid absorption, file e1dcb32b-e2f9-7715-e053-1705fe0a6cc9 2
Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study, file e1dcb32f-f762-7715-e053-1705fe0a6cc9 2
HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome, file e1dcb330-1201-7715-e053-1705fe0a6cc9 2
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF), file e1dcb330-1204-7715-e053-1705fe0a6cc9 2
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients, file e1dcb336-0b8e-7715-e053-1705fe0a6cc9 2
Ribavirin for chronic hepatitis C: And the mystery goes on., file e1dcb32c-001c-7715-e053-1705fe0a6cc9 1
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation., file e1dcb32c-4768-7715-e053-1705fe0a6cc9 1
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study, file e1dcb32d-37d7-7715-e053-1705fe0a6cc9 1
Viral hepatitis A and E, file e1dcb32e-e9f8-7715-e053-1705fe0a6cc9 1
null, file e1dcb330-1202-7715-e053-1705fe0a6cc9 1
Totale 954
Categoria #
all - tutte 2.393
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.393


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 1 2
2019/2020165 2 0 0 14 20 19 23 22 28 14 11 12
2020/2021121 9 15 2 4 11 14 9 14 10 15 15 3
2021/2022166 6 11 8 11 20 4 11 13 7 3 52 20
2022/2023277 6 18 51 43 44 26 18 16 27 15 13 0
2023/2024202 5 5 7 17 9 26 24 85 21 3 0 0
Totale 954